COMMISSION REGULATION (EU) 2021/644 of 15 April 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fluxapyroxad, hymexazol, metamitron, penflufen and spirotetramat in or on certain products ANNEX

Changelog

0 versions

Article-level history is being prepared

The official source publishes these consolidated versions; article-by-article changes will appear here as soon as they are processed.

No consolidated versions are recorded for this law.